VYNE Stock Price Increases Over 70% Pre-Market: Why It Happened

By Amit Chowdhry ● Jan 25, 2021
  • The stock price of Vyne Therapeutics Inc (NASDAQ: VYNE) increased by over 70% pre-market today as of 7:06 AM ET today. This is why it happened.

The stock price of Vyne Therapeutics Inc (NASDAQ: VYNE) increased by over 70% pre-market today as of 7:06 AM ET today. These are some of the reasons why.

The stock price of the company increased by over 13% in the past month. And about a month ago, Vyne passed the FDA process for advancing a third product called FCD105 for Phase 3 development.

FCD105 (3% minocycline / 0.3% adapalene foam) would be the first minocycline-based combination product, which is used for treating moderate-to-severe acne vulgaris. The Phase 3 trials are expected to happen in the first half of this year.

Investors also appear to be responding to a recent video published by Market Gains, which discussed the institutional investors that bought heavy stakes into the company recently.

 

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.